You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Open Label Ustekinumab for the treatment of antiTNF refractory moderatetosevere Crohn's disease: Follow up of a cohort of patients at an academic inflammatory bowel disease center: P4.

Rosen, Melissa; Scherl, Ellen; Bosworth, Brian

Inflammatory Bowel Diseases:
Clinical Poster Presentations

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.